Cite
HARVARD Citation
Ohlendorf, V. et al. (2022). Low anti‐HBc levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation in HBe antigen‐negative patients. Liver international. pp. 2674-2682. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ohlendorf, V. et al. (2022). Low anti‐HBc levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation in HBe antigen‐negative patients. Liver international. pp. 2674-2682. [Online].